Impact of Graft-versus-Host Disease Prophylaxis on Outcomes after Myeloablative Single-Unit Umbilical Cord Blood Transplantation-Reference-Cited by-同舟云学术

Impact of Graft-versus-Host Disease Prophylaxis on Outcomes after Myeloablative Single-Unit Umbilical Cord Blood Transplantation

Published:2013-09 Issue:9 Volume:19 Page:1387-1392
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Sanz Jaime,Picardi Alessandra,Hernández Boluda Juan C.,Martín Carmen,Ferrá Christelle,Nozzoli Chiara,Gonzalez-Vicent Marta,Rambaldi Alessandro,Valcarcel David,Verdeguer Amparo,Serrano David,de Heredia Cristina Díaz,Pascual María Jesús,de Paz Raquel,Montesinos Pau,Bartolozzi Benedetta,Algarotti Alessandra,Sanz Miguel A.,Arcese William,Sanz Guillermo F.

Funder

Pierre Fabre Ibérica

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference22 articles.

1. Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen;Sanz;Bone Marrow Transplant,2012

2. Incidence, risk factors, and outcome of cytomegalovirus infection and disease in patients receiving prophylaxis with oral valganciclovir or intravenous ganciclovir after umbilical cord blood transplantation;Montesinos;Biol Blood Marrow Transplant,2009

3. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors;Glucksberg;Transplantation,1974

4. 1994 Consensus Conference on Acute GVHD Grading;Przepiorka;Bone Marrow Transplant,1995

5. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients;Shulman;Am J Med,1980

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune reconstitution after single-unit umbilical cord blood transplantation using anti-thymoglobulin and myeloablative conditioning in adults with hematological malignancies;Annals of Hematology;2024-04-18

2. Comparison of two reduced intensity conditioning regimens: Flu-Bu2 versus RIC-TBF in allogeneic hematopoietic stem cell transplantation;Leukemia & Lymphoma;2023-11-21

3. Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01;Bone Marrow Transplantation;2022-04-12

4. Sirolimus versus cyclosporine in haploidentical stem cell transplantation with posttransplant cyclophosphamide and mycophenolate mofetil as graft‐versus‐host disease prophylaxis;eJHaem;2021-03-18

5. Central Nervous System Involvement in Epstein–Barr Virus-Related Post-Transplant Lymphoproliferative Disorders after Allogeneic Hematopoietic Stem Cell Transplantation;Transplantation and Cellular Therapy;2021-03